Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Xeljanz Xr
Xeljanz Xr Image

Xeljanz Xr

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Xeljanz Xr?

Xeljanz XR is a brand-name medication that contains the active ingredient tofacitinib. It belongs to a class of drugs called Janus kinase inhibitors, which work by suppressing the immune system to reduce inflammation in the joints. Xeljanz XR is specifically used to treat adults with moderate to severe rheumatoid arthritis who have not had an adequate response to other disease-modifying antirheumatic drugs (DMARDs). It helps to relieve the symptoms of joint swelling, pain, and stiffness, and can also help prevent further joint damage. This medication comes in an extended-release tablet form, which means it is designed to release the medication slowly into the body over time. The extended-release formulation allows for once-daily dosing, providing consistent levels of the drug in the bloodstream. It's important to note that Xeljanz XR may have potential side effects, including an increased risk of serious infections, blood clotting disorders, and problems with liver function. Therefore, it should only be used under the supervision of a healthcare professional, who will carefully weigh the benefits and risks for each individual patient. Overall, Xeljanz XR can be an effective treatment option for those with rheumatoid arthritis, but it's important to discuss all potential risks and benefits with a healthcare provider before starting this medication.

How to use Xeljanz Xr?

Xeljanz XR, also known by its generic name tofacitinib extended-release, is a medication used to treat rheumatoid arthritis. It is available in the form of extended-release tablets, which are taken orally. The dosage and administration of Xeljanz XR may vary depending on the individual's condition and response to treatment. It is important to follow the instructions provided by your healthcare provider. Generally, Xeljanz XR is taken once daily with or without food. Swallow the tablet whole, without chewing or crushing it. If you are prescribed Xeljanz XR, it is crucial to regularly monitor your blood cell counts and liver function, as this medication can affect these areas. Your healthcare provider will guide you on the necessary monitoring and advise any dose adjustments if needed. It's important to note that Xeljanz XR is a potent immunosuppressive medication, which means it suppresses the immune system. Hence, it's essential to be aware of the increased risk of infection while taking this medication. Report any signs of infection, such as fever, sore throat, or cough, to your healthcare provider. As with any medication, it's vital to take Xeljanz XR exactly as prescribed and communicate any concerns or side effects to your healthcare provider. They are best equipped to guide you through the proper usage of Xeljanz XR and ensure your treatment is effective and safe.

There are several important warnings associated with the use of Xeljanz XR (tofacitinib), a medication used to treat rheumatoid arthritis. It's essential to be aware of these warnings before starting this medication. 1. Serious infections: Xeljanz XR may increase the risk of developing serious infections, including tuberculosis (TB), bacterial, viral, and fungal infections. It is important to promptly report any signs of infection, such as fever, cough, or unusual discharge, to your healthcare provider. 2. Increased risk of malignancies: There is a potential increased risk of developing certain cancers, such as lymphoma, while taking Xeljanz XR. Inform your doctor if you have a history of cancer or are at a higher risk. 3. Blood clotting complications: Xeljanz XR can increase the risk of blood clotting, which may lead to deep vein thrombosis (DVT) or pulmonary embolism (PE). Inform your healthcare provider if you have a history of blood clots or are at a higher risk. 4. Gastrointestinal perforations: This medication may cause gastrointestinal perforations, which are holes or tears in the stomach or intestine. Let your doctor know if you experience severe abdominal pain, bloody stools, or vomiting. 5. Decreased immune response: Xeljanz XR can weaken the immune system, making it easier for infections to occur. This may be particularly important for individuals who are already prone to infections or have other medical conditions. 6. Hepatitis B reactivation: If you have a history of hepatitis B infection, Xeljanz XR may reactivate the virus. Make sure to inform your doctor if you have or have had hepatitis B. It's crucial to discuss these warnings and any other concerns with your healthcare provider before starting Xeljanz XR. They will carefully assess the potential risks and benefits to determine if this medication is appropriate for you. Regular monitoring and follow-up appointments with your doctor are essential while taking Xeljanz XR to ensure optimal safety and effectiveness.

Before taking Xeljanz XR (tofacitinib extended-release), it is important to be aware of several warnings and precautions associated with the medication. Firstly, Xeljanz XR is not recommended for individuals with a current, serious, or recurrent infection, as it can weaken the immune system and make it harder for the body to fight off infections. Prior to starting treatment, it is essential to inform your healthcare provider about any current or past infections. Secondly, Xeljanz XR may increase the risk of developing certain serious infections, including tuberculosis (TB), bacterial or viral infections, and fungal infections. Symptoms of infection, such as fever, cough, or persistent flu-like symptoms, should be promptly reported to your doctor. Additionally, Xeljanz XR can affect the body's ability to produce blood cells, leading to an increased risk of anemia, lymphoma, and other blood disorders. Regular blood tests may be required to monitor for any abnormalities. Furthermore, there have been reports of gastrointestinal perforations (holes in the stomach or intestines) in individuals taking Xeljanz XR. It is recommended to seek immediate medical attention if you experience severe stomach pain or vomiting. It is important to note that Xeljanz XR carries a boxed warning regarding the increased risk of blood clots in the lungs and death when used in higher doses for rheumatoid arthritis. The medication should be used cautiously in individuals who have a history of blood clots or other cardiovascular conditions. Other precautions include avoiding live vaccines while on Xeljanz XR and informing your healthcare provider about all current medications, including over-the-counter drugs and herbal supplements, as they may interact with Xeljanz XR. Ultimately, it is crucial to discuss the potential risks and benefits of Xeljanz XR treatment with your healthcare provider before initiating therapy. They will be able to provide personalized advice based on your medical history and individual circumstances.

Xeljanz XR is a brand-name medication that contains the active ingredient tofacitinib. It is primarily prescribed to treat rheumatoid arthritis, a chronic autoimmune disorder that causes inflammation in the joints. While Xeljanz XR can provide relief for individuals with rheumatoid arthritis, it is important to be aware of potential side effects. Some common side effects of Xeljanz XR include headache, diarrhea, nausea, and upper respiratory tract infections. In addition, there are more serious side effects that may occur with this medication. These side effects include an increased risk of infection, such as pneumonia or tuberculosis, and an increased risk of malignancies, such as lymphoma. Other notable side effects include liver enzyme elevations, blood in the urine, and changes in cholesterol levels. If you experience any side effects while taking Xeljanz XR, it is crucial to inform your healthcare provider. They can provide guidance on managing the side effects and determine if any adjustments to your treatment plan are necessary. Please note that it is essential to consult with a healthcare professional before taking any medication and to follow their instructions closely. This information is not a substitute for medical advice.

Xeljanz XR is a brand-name medication known generically as tofacitinib. The active ingredient in Xeljanz XR is tofacitinib citrate, which is a Janus kinase (JAK) inhibitor. It works by blocking certain enzymes that are involved in the inflammation process, thereby reducing the symptoms of rheumatoid arthritis. In addition to the active ingredient, Xeljanz XR also contains other inactive ingredients, including: 1. Hypromellose: a cellulose derivative that helps to form the extended-release tablet. 2. Microcrystalline cellulose: a commonly used binder and filler in pharmaceutical formulations. 3. Sodium starch glycolate: a disintegrant that helps the tablet break down and release the medication in the body. 4. Colloidal silicon dioxide: an anti-caking agent that helps prevent clumping of the tablet ingredients. 5. Magnesium stearate: a lubricant that aids in the manufacturing process of the tablet. 6. Polyethylene glycol: a polymer used to enhance the dissolution of the tablet. 7. Red iron oxide: a coloring agent used to give the tablet its distinctive color. It's important to note that the inactive ingredients in Xeljanz XR may vary slightly depending on the specific dosage strength and formulation. It is always recommended to consult the medication label or a healthcare professional for the most accurate and up-to-date information.

Xeljanz XR, also known as tofacitinib extended-release, is a prescription medication used for the treatment of rheumatoid arthritis. When it comes to storing Xeljanz XR, it is important to follow certain guidelines to maintain its effectiveness and ensure your safety. The medication should be stored at room temperature, typically between 68°F and 77°F (20°C and 25°C). It is important to keep the medication in its original container, tightly sealed, and away from moisture and heat sources such as direct sunlight, hot surfaces, or humid environments like bathrooms. Additionally, it's crucial to keep Xeljanz XR out of the reach of children and pets to prevent accidental ingestion. If you have any unused or expired Xeljanz XR, it is advised to dispose of it properly following the guidelines provided by your healthcare professional or local disposal regulations. Do not flush the medication down the toilet unless specifically instructed to do so. Remember, always consult your healthcare provider or pharmacist if you have any specific questions regarding the storage or handling of Xeljanz XR.